Online Self-Help as an Add-On to Inpatient Psychotherapy: Efficacy of a New Blended Treatment Approach by Zwerenz, Rüdiger et al.
 
 
 
 
 
Dieses Dokument ist eine Zweitveröffentlichung (Verlagsversion) / 
This is a self-archiving document (published version):  
 
 
 
 
 
 
 
 
 
 
Diese Version ist verfügbar / This version is available on:  
https://nbn-resolving.org/urn:nbn:de:bsz:14-qucosa2-706284 
 
 
 
 
 
„Dieser Beitrag ist mit Zustimmung des Rechteinhabers aufgrund einer (DFGgeförderten) Allianz- bzw. 
Nationallizenz frei zugänglich.“ 
 
This publication is openly accessible with the permission of the copyright owner. The permission is 
granted within a nationwide license, supported by the German Research Foundation (abbr. in German 
DFG). 
www.nationallizenzen.de/ 
 
Rüdiger Zwerenz, Jan Becker, Rudolf J. Knickenberg, Martin Siepmann, Karin Hagen, 
Manfred E. Beutel 
Online Self-Help as an Add-On to Inpatient Psychotherapy: Efficacy of 
a New Blended Treatment Approach 
 
Erstveröffentlichung in / First published in: 
Psychotherapy and Psychosomatics. 2017, 86 (6), S. 341 – 350 [Zugriff am: 19.05.2020]. 
Karger. ISSN 1423-0348.  
DOI: https://doi.org/10.1159/000481177    
  
E-Mail karger@karger.com
 Regular Article  
 Psychother Psychosom 2017;86:341–350 
 DOI: 10.1159/000481177 
 Online Self-Help as an Add-On to 
Inpatient Psychotherapy: Efficacy of a 
New Blended Treatment Approach 
 Rüdiger Zwerenz  a    Jan Becker  a    Rudolf J. Knickenberg  b    Martin Siepmann  b, c    
Karin Hagen  b    Manfred E. Beutel  a 
 a   Department of Psychosomatic Medicine and Psychotherapy, University Medical Center, Johannes Gutenberg 
University Mainz,  Mainz ,  b   Clinic for Psychosomatic Medicine, Rhön-Klinikum AG,  Bad Neustadt/Saale , and 
 c   Department of Psychosomatic Medicine and Psychotherapy, University Medical Center, Carl Gustav Carus 
Technical University,  Dresden , Germany
 
come at the end of the intervention (T2).  Results: Depressive 
symptoms were statistically significantly lower in the IG 
compared to the active CG at T2 with a moderate between-
group effect size of  d = 0.44. The same applied to anxiety 
( d = 0.33), quality of life ( d = 0.34), and self-esteem ( d = 0.38) 
at discharge from inpatient treatment (T1). No statistically 
significant differences were found regarding dysfunctional 
attitudes ( d = 0.14) and work ability ( d = 0.08) at T1.  Conclu-
sions: This is the first evidence for blended treatment com-
bining online self-help with inpatient psychotherapy. The 
study opens new and promising avenues for increasing the 
efficacy of inpatient psychotherapy. Future studies should 
determine how integration of online self-help into the thera-
peutic process can be developed further. 
 © 2017 S. Karger AG, Basel 
 Introduction 
 Affecting an estimated 38.2% of the population of the 
European Union  [1] , mental disorders constitute one of 
the most challenging global health care problems  [2] , 
often taking a chronic course and resulting in high med-
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 Abstract 
 Background: Depression is one of the most frequent and 
costly mental disorders. While there is increasing evidence 
for the efficacy of online self-help to improve depression or 
prevent relapse, there is little evidence in blended care set-
tings, especially combined with inpatient face-to-face psy-
chotherapy. Therefore, we evaluated whether an evidence-
based online self-help program improves the efficacy of in-
patient psychotherapy.  Methods: A total of 229 depressed 
patients were randomly allocated either to an online self-
help program (intervention group [IG]; Deprexis) or an active 
control group (CG; weekly online information on depression) 
in addition to inpatient psychodynamic psychotherapy. 
Both groups had access to their respective experimental in-
tervention for 12 weeks, regardless of inpatient treatment 
duration. Reduction of depressive symptoms, as measured 
with the Beck Depression Inventory-II, was the primary out-
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ical, indirect, and nonmedical costs  [3] . Even though ef-
fective evidence-based treatments have been established, 
only a minority of 10–50% of depressed individuals re-
ceives them in an adequate and timely manner  [4, 5] . In 
order to provide instant, flexible help with low barriers, 
online self-help interventions have been developed. 
They have been found to be effective in numerous ran-
domized controlled trials with samples recruited over 
the internet, particularly when combined with some de-
gree of basic therapeutic support  [6–8] . In recent meta-
analyses self-guided internet-based cognitive behavioral 
therapy proved to be significantly more effective com-
pared to control groups regarding depressive symptom 
severity  [9] , subthreshold depression  [10] , and preven-
tion of depressive disorders  [11] . Deprexis is an interac-
tive internet-based self-help program which does not 
necessarily require therapist support. A recent meta-
analysis  [12] based on 8 studies demonstrated posttreat-
ment effectiveness for depressive symptoms with a me-
dium effect size of  d = 0.54 (95% CI: 0.39–0.69). Findings 
on the applicability of online self-help for primary care 
patients have been mixed, especially when offered in 
usual care settings  [13] . A large, independent evaluation 
of 2 unsupported computerized cognitive behavioral in-
terventions, which had proved to be effective in devel-
oper-led trials, found no significant effect in a primary 
care setting as an add-on compared to usual care  [14] , 
mainly due to low adherence to the online treatment and 
probably to some extent due to the lack of therapeutic 
support. On the other hand, preliminary studies have 
indicated that web-based interventions can be com-
bined with face-to-face psychotherapy in a meaningful 
way, e.g., by increasing the adherence and effectiveness 
of conventional therapy  [15, 16] or saving therapist time 
 [17–19] .
 Online programs have been used successfully to pre-
vent relapse in patients with remitted depression  [20–22] 
following outpatient or inpatient psychotherapy or reha-
bilitation in order to maintain treatment gains in recent 
trials  [23, 24] . However, we are not aware of a trial exam-
ining the efficacy of an online self-help program in addi-
tion to inpatient psychotherapy. Inpatient psychotherapy 
for acute or chronic depression is indicated when symp-
tomatology is severe and complex, and when outpatient 
psychotherapy or psychopharmacotherapy is not suffi-
cient  [25, 26] . Even though inpatient psychotherapy has 
been shown to improve depressive symptoms consider-
ably  [27–29] , patients do not fully remit within 4–8 weeks, 
and they are at an increased risk for relapse or readmis-
sion  [30, 31] .
 The purpose of this paper is to determine (1) if de-
pressed inpatients accept the offer of additional online 
self-help, (2) if the adjunct treatment improves the out-
come of inpatient psychotherapy, and (3) if it supports 
stabilization of positive treatment effects beyond inpa-
tient treatment. We assume that an online self-help pro-
gram is well accepted by patients and increases the effi-
cacy of inpatient treatment. 
 Methods 
 Participants 
 We recruited a total of 229 patients in the Psychosomatic Clin-
ic in Bad Neustadt/Saale, Germany, from July 2014 to February 
2016. To be eligible, patients were required to be aged 18–65 years 
and to have private internet access, sufficient German language 
proficiency, a score in the Beck Depression Inventory (BDI-II) 
above 13, and a clinical diagnosis of depression (ICD-10: F32.x, 
F33.x, F34.1, F43.2). Exclusion criteria specified (1) diagnosis of 
psychosis (F20–F29), (2) current alcohol or drug addiction (F10–
F19), (3) borderline (F60.3), antisocial (F60.2), schizoid (F60.1), 
and schizotypal (F21) personality disorders, (4) anorexia nervosa 
(F50.0), and (5) lifetime diagnoses of schizophrenia (F20–F29), 
schizoaffective (F25), bipolar (F31), or organic (F00–F09) mental 
disorder. Diagnoses were made by the individual therapist of the 
patient under regular supervision, based on ICD-10 criteria.
 Eligible patients were invited to the weekly study information 
session by the study assistant where they got oral and written in-
formation about the study and the requirements for participation. 
The interventions were briefly presented to therapists, who were 
informed about their patients’ study participation but had no ac-
tive role in any add-on treatment.
 Procedure 
 Patients who gave their written informed consent to participate 
were coded and randomized to either the intervention group (IG) 
or the control group (CG). After randomization, the study assis-
tant gave each participant a login code and introduced the self-help 
intervention (Deprexis) and the online information platform (IG 
and CG, respectively). The trial protocol, including the concept for 
protection of data privacy, the study information, and forms for 
the written informed consent, were approved by the Ethics Com-
mittee of the Statutory Physician Board of the State of Rhineland 
Palatinate (Ref. No. 837.093.14 [9332-F]). All procedures involved 
in this study follow the ICH-GCP guidelines. The trial was regis-
tered at Clinicaltrials.gov (identifier: NCT02196896), and the trial 
protocol was published elsewhere  [32] .
 Intervention 
 Inpatient psychodynamic psychotherapy consists of individual 
and group psychotherapy, creative psychotherapy interventions, 
and adjunct treatments like patient education and physical train-
ing. Additionally, a 12-week access to the online self-help interven-
tion was offered. Deprexis is divided into 10 main modules plus 1 
introductory and 1 summary module. Although labeled as cogni-
tive behavioral, the eclectic program uses techniques from differ-
ent psychotherapeutic orientations like cognitive behavioral psy-
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chotherapy, positive psychology, emotion-focused therapy, and 
dream work. A dialogue-like concept guides the user through the 
intervention, presenting a text block with optional graphics, exer-
cises, audio files, and answering options. Subsequent text blocks 
are based on the user’s choices. A new module is presented to the 
user only after completing the prior module; thus the user pro-
gresses at his or her own pace. Optional reminders via e-mail and 
SMS can be activated  [33] .
 Participants were assigned two 1-h time slots in their weekly 
treatment plan, but they were free to use the intervention beyond 
these slots. After discharge from inpatient treatment, participants 
had access to Deprexis for the remaining time of a total duration of 
12 weeks. Follow-up results will be described in another publication.
 Control Condition 
 In addition to inpatient psychotherapy (treatment as usual 
[TAU]) the CG had access to an online platform providing 12 
weekly modules with specific topics regarding depression. This in-
formation was gathered, structured, and presented by the study 
center with permission from reliable and freely available internet 
sources. Most of the content was taken from the patient version of 
the German medical guidelines  [34] , the German network on de-
pression  [35] , and health insurance companies. Information fo-
cused on clinical signs and diagnosis, etiology, course of depres-
sion, psychotherapeutic and pharmacological treatments, and self-
help options. One consecutive module was automatically activated 
on a weekly basis over a period of 12 weeks. To ensure comparabil-
ity with the IG, the CG was also given 2 different weekly time slots 
of equal length in their treatment plan to use the online platform. 
 Outcome Measures 
 All measures were based on self-report and collected using the 
online survey platform SoSci Survey  [36] , accessible online at 
https://www.soscisurvey.de. 
 Primary Outcome 
 The primary outcome was depressive symptoms at the end of 
inpatient treatment, as measured by the BDI-II  [37] ), a reliable and 
valid instrument  [38, 39] . Cronbach’s α in this study was 0.92.
 Secondary Outcomes 
 Depressive symptoms were additionally assessed with the Pa-
tient Health Questionnaire-9 (PHQ-9), a module of the PHQ with 
well-established psychometric properties  [40] . Anxiety was mea-
sured with the General Anxiety Disorder-7 (GAD-7), with verified 
reliability and validity  [41] . Quality of life was assessed with the 
EUROHIS-QOL 8-item index  [42] , a shortened version of the 
World Health Organization Quality of Life Instrument-Abbreviat-
ed Version (WHOQOL-BREF), with proven reliability and validity 
 [42] . Self-esteem was measured with the reliable and valid Rosen-
berg Self-Esteem Scale (RSE)  [43] . Dysfunctional attitudes related 
to depressive thinking were measured with the reliable and valid 
Dysfunctional Attitudes Scale (DAS)  [44] . Work ability was mea-
sured with the short version of the Work Ability Index (WAI)  [45] , 
a predictive, reliable, and internationally validated instrument  [46] .
 Further Analyses 
 Satisfaction with the online interventions was measured on 
5-point Likert scales (ranging from “not at all” to “somewhat” to 
“very”) with the item “How satisfied are you with Deprexis?” (re-
spectively the online information in the active control condition). 
The influence of the intervention on the inpatient therapy was 
measured with the item “How did Deprexis/online information 
influence the treatment outcome of your inpatient therapy?” 
(ranging from “very negative” to “no influence” to “very positive”). 
To identify the intensity of use of the intervention, patients were 
asked “How often did you use Deprexis/the information on the 
internet platform?” (“never,” “less than once a week,” “once a 
week,” “several times a week”).
 Patients and therapists filled out the German version of the 
Helping Alliance Questionnaire (HAQ)  [47] , a standardized in-
strument to assess therapeutic alliance with good reliability and 
validity at discharge. 
 Sample Size Calculation 
 Power calculation was based on an effect size of  d = 0.50, a 
power of 0.80, and an alpha error of 0.05 (2-sided). To detect this 
effect size, a sample size of  n = 128 is necessary. Based on the sam-
ple size of  n = 230, the study had a power of 0.97 to detect an effect 
size of  d = 0.50 or higher. A more detailed description of power 
calculation is described elsewhere  [32] .
 Randomization 
 Participants were randomly assigned to the IG or CG using 
block randomization at a ratio of 1: 1. Randomization was con-
ducted with the software Research Randomizer  [48] by the Study 
Center of Mental Disorders, an independent institution of the Uni-
versity Medical Center Mainz.
 Data Analyses 
 All analyses were based on intention to treat. Missing data were 
imputed with IBM SPSS Statistics 23 using a Markov Chain Mon-
te Carlo multivariate imputation algorithm with 5 imputations, 10 
estimations per missing value, and a constraint of a maximum of 
60% missing data. We used unpaired  t tests to compare responders 
and nonresponders for baseline differences, analyses of covariance 
(ANCOVA) to compare outcomes between groups at the end of 
treatment (controlling for baseline scores), and paired-samples  t 
tests for the analysis of pre-post change in outcome measures with-
in subjects. Reported are means and standard deviations for be-
tween-group analyses (ANCOVA),  t test statistics, and effect sizes 
(Cohen’s  d ). Cohen’s  d for between-group comparisons was calcu-
lated using the estimated means from the ANCOVA to control for 
baseline scores and the pooled standard deviations corrected for 
different group sizes. Cohen’s  d for within-group comparisons was 
calculated following the method of Dunlap et al. [ 49 , p. 171], cor-
recting for the correlation between the 2 measures in order to avoid 
overestimation of effects. All analyses were conducted on a 2-sided 
level of significance of 0.05. Data analyses were conducted with 
IBM SPSS Statistics 23  [50] .
 Results 
 Study Flow and Participant Characteristics 
 Figure 1 shows the flow of participants in the study 
until the end of the intervention (T2). Out of 611 patients 
assessed for eligibility, 382 (63%) were excluded from the 
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study for not meeting inclusion criteria (22%), declining 
to participate (30%), or not attending the study informa-
tion sessions because of organizational constraints such 
as scheduling problems, relocation to another clinic, or 
early discharge (11%). Thus, a total of 229 (37%) patients 
were randomized, with 115 allocated to the IG and 114 to 
the CG; 109 patients in the IG and 110 in the CG received 
the respective intervention. At the end of inpatient treat-
ment (T1), 198 (86%) participants completed the assess-
ment: 88% in the IG and 85% in the CG. At the end of the 
intervention (T2) 170 (74%) participants completed the 
assessment: 74% in the IG and 75% in the CG. Dropout 
rates were low, with 3% at T0 (did not start intervention), 
4% at T1, and 3% at T2, with no differences in dropout 
rates between IG and CG.
 Analyses revealed that the participants who completed 
the T2 assessments did not differ from those participants 
who dropped out from assessments concerning baseline 
mental symptoms like our primary outcome (BDI-II; 
t 213 = –0.017;  p = 0.986), depressive symptoms (PHQ-9; 
 t 200 = 0.962;  p = 0.337), generalized anxiety (GAD-7; 
 t 200 = 0.138;  p = 0.890), quality of life (EUROHIS-QOL 8; 
 t 199 = 0.756;  p = 0.450), self-esteem (RSE;  t 200 = 0.652;  p = 
0.515), dysfunctional attitudes (DAS;  t 199 = 0.483;  p = 
0.630), or self-assessed work ability (WAI;  t 198 = 0.030; 
p = 0.976). For all analyses concerning the outcome mea-
sures, 14 patients were excluded due to missing assess-
ments at T0 and T1 ( n = 8) or meeting exclusion criteria 
( n = 6). Overall, 215 participants were analyzed after im-
puting missing data.
Assessed for eligibility
(n = 611)
Randomized (n = 229)
Allocation (T0)
End of inpatient
treatment (T1)
Enrollment
End of 
intervention (T2)
Analysis
Excluded (n = 382)
n = 135)
n = 180)
n = 67)
Allocated to active control group (n = 114)
n = 110)
 (no  login) (n = 4)
Allocated to intervention group (n = 115)
n = 109)
 (no  login) (n = 6)
Lost to T1 (n = 17)
n = 5)
Lost to T1 (n = 14)
n = 3)
Lost to T2 (n = 29)
n = 4)
Lost to T2 (n = 30)
n = 2)
Analyzed (n = 107)
n = 7)
n = 2)
n = 5)
Analyzed (n = 108)
n = 7)
n = 6)
n = 1)
 Fig. 1. CONSORT flow diagram showing the flow of participants in the study until the end of the intervention 
(T2). 
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 Sociodemographic and medical characteristics of the 
study sample are shown in  Table 1 . Participants were pre-
dominantly female (60.7%) and had a mean age of 48 ± 
9.79 years (range: 18–65). About half of the participants 
were married (50.2%), graduated from middle or higher 
secondary level (58.1%), and worked full-time (47.6%), 
with 56.3% being on sick leave at study intake. The mean 
inpatient treatment duration was 40 ± 7.51 days (range: 
11–78) with no difference between IG (41 ± 7.43) and CG 
(40 ± 7.58). Previous psychopharmacotherapy and psy-
 Table 1.  Demographic and medical characteristics: intervention group (IG) versus control group (CG)
Variable IG CG Total
(n = 115) (n = 114) (n = 229)
Age (mean ± SD), years 47.36 ± 10.38 48.61 ± 9.16 47.98 ± 9.79
Sex
Male 41 (35.7) 49 (43) 90 (39.3)
Female 74 (64.3) 65 (57) 139 (60.7)
Marital status
Single 27 (23.5) 25 (21.9) 52 (22.7)
Married 53 (46.1) 62 (54.4) 115 (50.2)
Separated 9 (7.8) 4 (3.5) 13 (5.7)
Divorced 25 (21.7) 19 (16.7) 44 (19.2)
Widowed 1 (0.9) 4 (3.5) 5 (2.2)
Graduation
No graduation 16 (13.9) 21 (18.4) 37 (16.2)
Lower secondary 22 (19.1) 15 (13.2) 37 (16.2)
Middle secondary 34 (29.6) 31 (27.2) 65 (28.4)
Higher secondary 31 (27.0) 37 (32.5) 68 (29.7)
Other 12 (10.5) 10 (8.8) 22 (9.6)
Employment status
Full-time 55 (47.8) 54 (47.4) 109 (47.6)
Regular part-time 29 (25.2) 17 (14.9) 46 (20.1)
Apprenticeship 3 (2.6) 1 (0.9) 4 (1.7)
Retired 3 (2.6) 8 (7.1) 11 (4.8)
Not working 14 (12.1) 24 (21) 38 (16.6)
Other 11 (9.6) 10 (8.8) 21 (9.1)
Sick leave at intake
Yes 68 (59.2) 61 (53.5) 119 (56.3)
No 35 (30.4) 38 (33.3) 73 (31.9)
Missing 12 (10.4) 15 (13.2) 27 (11.8)
Previous medication
No 42 (36.5) 35 (30.7) 77 (33.6)
Yes, up to 3 months 11 (9.6) 9 (7.9) 20 (8.7)
Yes, 3 – 6 months 10 (8.7) 13 (11.4) 23 (10.0)
Yes, 6 – 12 months 13 (11.3) 9 (7.9) 22 (9.6)
Yes, longer than 12 months 39 (33.9) 48 (42.1) 87 (38.0)
Previous treatment
No 43 (37.4) 27 (23.7) 70 (30.6)
Yes, 1 treatment 31 (27.0) 39 (34.2) 70 (30.6)
Yes, 2 or more treatments 41 (35.7) 48 (42.1) 89 (38.9)
Antidepressant medication during treatment
No 45 (39.1) 34 (30.4) 79 (34.8)
New 10 (8.7) 11 (9.8) 21 (9.3)
Stable 48 (41.7) 55 (49.1) 103 (45.4)
Reduced 8 (7.0) 7 (6.3) 15 (6.6)
Other (e.g., dose increased or change of substance) 4 (3.5) 5 (4.5) 9 (4.0)
Values are n (%) unless otherwise indicated.
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chotherapeutic treatments were comparable in the IG 
and CG as well as the status of antidepressant medication 
during inpatient treatment ( Table 1 ). 
 Outcome Measures 
 Table 2 reports means and standard deviations for the 
primary outcome (BDI-II) at intake (T0), discharge (T1), 
and at the end of the intervention (T2), as well as test sta-
tistics and effect sizes. At baseline, there were no signifi-
cant differences between the 2 groups regarding any out-
come measures. At the end of the intervention (T2) both 
groups significantly improved concerning depressive 
symptoms assessed with the BDI-II, but within-group ef-
fect size was higher in the IG ( d = 1.12) than in the CG 
( d =  0.56), reflecting a medium between-group effect size 
difference ( d = 0.44). 
 At discharge (T1) within-group effect sizes for the BDI-
II were similarly high (IG:  d = 1.18; CG:  d = 0.69), as were 
the between-group effect size ( d = 0.48). The same applied 
to several secondary outcomes at T1 (see online suppl. Ta-
ble 1; see www.karger.com/doi/10.1159/000481177 for all 
online suppl. material) such as depression scores measured 
with the PHQ-9 ( d = 0.40). Significant between-group dif-
ferences were also found regarding anxiety (GAD-7;  d = 
0.33), quality of life (EUROHIS-QOL 8;  d = 0.34) and self-
esteem (RSE;  d = 0.38). No significant between-group dif-
ferences were found concerning dysfunctional attitudes 
(DAS;  d = 0.14) and work ability (WAI;  d = 0.08).
 Further analyses at discharge (T1) revealed that 78% of 
the participants in the IG were quite or very satisfied with 
the intervention compared to 50% in the CG (χ 2 1 = 17.59; 
 p < 0.001;  d = 0.88); 62% in the IG stated that the online 
intervention had a positive or very positive influence 
compared to 34% in the CG (χ 2 1 = 19.78;  p < 0.001;  d = 
 0.64); 83% in the IG and 78% in the CG used their respec-
tive intervention at least once per week (χ 2 1 = 1.03;  p = 
0.46;  d = 0.13). However, 46% of the IG reported that they 
used their intervention several times a week compared to 
24% in the CG.
 At the end of the intervention (T2) 79% of the partici-
pants in the IG were quite or very satisfied with the inter-
vention compared to 46% in the CG (χ 2 1 = 25.98;  p < 
0.001;  d = 0.74); 42% in the IG and 25% in the CG used 
their respective intervention at least once per week (χ 2 1 = 
7.67;  p = 0.02;  d = 0.39). Self-reported utilization of 
Deprexis compared to the active control condition is il-
lustrated for the 2 groups and 2 time points in online sup-
plementary Figure 1. 
 At study intake patient HAQ was significantly high-
er in the IG than in the CG (4.35 ± 0.64 vs. 4.15 ± 0.78;  Ta
b
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 t 213 = 2.15;  p = 0.03;  d = 0.30), and therapist HAQ was 
comparable in both groups (IG: 4.50 ± 0.59 vs. CG: 4.46 
± 0.57;  t 213 = 0.61;  p = 0.54;  d = 0.08). HAQ scores were 
slightly higher at discharge in both groups (IG: 4.55 ± 
0.71 vs. CG: 4.42 ± 0.71;  F 1, 212 = 1.71;  p = 0.202;  d = 0.18), 
with a tendency to a higher therapist HAQ in the IG (IG: 
4.74 ± 0.55 vs. CG: 4.59 ± 0.55;  F 1, 212 = 3.74;  p = 0.057; 
 d = 0.26). 
 Discussion 
 While the efficacy of Deprexis has been evaluated fa-
vorably in the treatment of various depressed samples, we 
have little knowledge about its acceptance and efficacy in 
blended care approaches  [12] . A recent trial with 1,013 
participants  [51] in different clinical and nonclinical set-
tings demonstrated the effectiveness of Deprexis as an 
add-on to usual care, with a between-group effect size 
concerning depressive symptoms (PHQ-9) of  d = 0.39 
posttreatment (3 months) and  d = 0.32 at the 6-month 
follow-up compared to care as usual alone (psychological 
and/or pharmacological treatments).
 Multimodal inpatient psychotherapy is the treatment 
of choice for patients with severe, complex, and chronic 
depression in Germany  [27] . We aimed at reducing de-
pression further than usual by engaging self-help poten-
tials of the patients, which may not be fully accessed by 
inpatient psychotherapy and bridge the gap from inpa-
tient treatment to aftercare. The focus of this paper was 
on the acceptance and efficacy of blended care (inpatient 
psychotherapy as usual plus online self-help) versus an 
active CG (inpatient psychotherapy plus online informa-
tion about depression) from intake to termination of on-
line self-help after 12 weeks. 
 Acceptance in general – regarding participation rates 
of the patients recruited – was good, with only 30% of 
eligible patients refusing to take part in the study. Our 
refusal rate was lower than in similar studies, where 57% 
of eligible patients declined to participate in a transdiag-
nostic internet-based maintenance treatment after inpa-
tient psychotherapy  [23] . Patients refusing participation 
in our study were comparable regarding the BDI-II scores 
at baseline (29.60 vs. 30.04) and had a comparable age 
(47.4 vs. 48.0 years) and sex composition (65% vs. 61% 
females). 
 Usual care treatment augmented by Deprexis had a 
large effect size of  d = 1.12 regarding the BDI in the with-
in-group comparison at the end of the intervention and 
an additional moderate effect regarding the primary out-
come compared to the active control condition. At dis-
charge from the hospital, considerable benefits could be 
shown for depression (BDI-II and PHQ-9), anxiety, qual-
ity of life, and self-esteem, but not for other outcomes like 
depressive thinking styles or work ability. A previous 
study  [52] concluded that dysfunctional cognitions of de-
pressive inpatients are relatively stable compared to de-
pressive symptoms. Similarly, self-perceived work ability 
is also expected to change slowly  [53] . As Deprexis is 
geared at reducing depressive symptoms, not specifically 
at increasing work ability or vocational reintegration, im-
proved work ability could only be expected as an indirect 
effect of depressive symptom reduction.
 Overall, the great majority reported having accessed 
the intervention (80%) or the online material. These high 
proportions may result from integrating online sessions 
in the treatment plans. Nearly twice as many participants 
used Deprexis at least once a week after discharge com-
pared to the utilization of the online information in the 
CG (42 vs. 25%). This corresponds to findings that online 
self-help (e.g., MoodGYM) was more frequently used 
than informational online pages alone  [54] .
 To our knowledge this is the first study with Deprexis 
as an add-on to inpatient psychotherapy. Compared to 
previous studies an increase in efficacy was substantial – 
especially when considering that inpatient psychotherapy 
yielded medium effect sizes in the CG when assessed at 
the end of intervention, several weeks after discharge 
from the hospital. Retention in our study was excellent, 
with 86% completing the questionnaires at discharge and 
74% at termination of the intervention, exceeding previ-
ous studies. Taken together with the high acceptance, the 
findings underscore the feasibility of the additional self-
help on behalf of the patients.
 Implementing a blended care approach in an estab-
lished treatment setting also raises the issue of feasibility 
and acceptance on behalf of the therapists. When the pro-
gram was initially presented, therapists raised concerns of 
overburdening depressed patients in a “full-time” treat-
ment setting and of adversely affecting the therapeutic 
relationship by adding online CBT to a psychodynamic 
setting. Taken together, our findings on acceptance, re-
tention, and outcome support the view that a diverse 
and structured setting may lend itself to adding another 
therapeutic online modality. Rather than overburdening 
them, patients achieved stronger and more lasting treat-
ment effects, and we found no adverse effects on the ther-
apeutic alliance from the therapist and the patient per-
spective.
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 Limitations 
 In order to control for the effect of additional and reg-
ular internet inquiry, we used a TAU plus online informa-
tion as the CG. Thus, we had no TAU only condition. 
However, it seems unlikely that information had a strong 
impact. Effect sizes in the CG at the end of intervention 
were in the medium range, comparable to a previous 
meta-analysis on inpatient psychotherapy with compa-
rable duration  [55] . As the study was implemented under 
naturalistic conditions, the patients were screened by 
their individual therapists and scheduled for the study in-
formation session by the study assistant. Thus, we cannot 
preclude that depressive patients were not screened or 
scheduled under the time constraints of a comparatively 
short clinical treatment. While only 30% of eligible pa-
tients declined participation, some patients may not have 
attended information sessions as they were unwilling to 
participate in the trial. According to our assessment plan, 
we assessed the primary outcome – the BDI-II – at all 
times. However, secondary outcomes were only assessed 
at discharge from the hospital and at follow-up (to be an-
alyzed and published separately). Unfortunately, as we 
lacked objective data on the degree of Deprexis complet-
ed to define a priori completer status, we resorted to ana-
lyzing the subjective reports of participants concerning 
their utilization of Deprexis as well as the control condi-
tion. 
 As sessions for online participation needed to be 
scheduled and we could not prohibit patients from talk-
ing about their study intervention to their therapist, we 
could not blind the therapists to the status of enrolment 
of their patients. As therapists had voiced concerns of 
whether participation might compromise collaboration 
of patients in the psychodynamic program, we did not 
expect them to explicitly encourage self-help participa-
tion. While we had therapists and patients fill out thera-
peutic alliance measures for their usual treatment, we had 
no direct measure of whether contents of online self-help 
were raised in face-to-face treatments. Our findings raise 
the issue of whether the effectiveness of a blended care 
approach could be further enhanced by integrating it 
more into the inpatient program. Furthermore, since the 
effect of guidance on the efficacy of internet-based inter-
ventions is still controversially discussed  [56] , our study 
would have benefitted from a subgroup of participants 
with therapeutic guidance to explore the effect of thera-
peutic interventions. Finally, we are aware that we com-
pared treatment packages with multiple effective ingredi-
ents  [57] and that we could not control how Deprexis was 
supported by the different members of the staff. Future 
investigations should determine how integration of on-
line self-help into the therapeutic process can be devel-
oped further, e.g., by garnering and enhancing staff sup-
port.
 Despite these limitations, our study delivers the first 
evidence for blended treatment combining online self-
help with inpatient psychotherapy and opens new and 
promising avenues for increasing the efficacy of inpatient 
psychotherapy.
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